e-learning
resources
Munich 2014
Sunday, 07.09.2014
The assessment of comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiovascular comorbidity in COPD: Tip of iceberg
G. Chawla, A. P. Kansal, K. Kaur, K. Deep (Patiala, India)
Source:
International Congress 2014 – The assessment of comorbidities
Session:
The assessment of comorbidities
Session type:
Thematic Poster Session
Number:
985
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Chawla, A. P. Kansal, K. Kaur, K. Deep (Patiala, India). Cardiovascular comorbidity in COPD: Tip of iceberg. Eur Respir J 2014; 44: Suppl. 58, 985
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Late Breaking Abstract - Developing the pneumonia-optimized ratio for community-acquired pneumonia: an easy, inexpensive and accurate prognostic biomarker
Related content which might interest you:
Factors influencing cognitive function in COPD
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Symptoms for anxiety and depression in COPD patients
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Pharmacological treatment of COPD in the on-sint cohort
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Main and additional predictors of COPD progression
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
The German COPD cohort COSYCONET: Aims, methods and results of recruitment
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
COPD telemonitoring: Analysis of hospital admissions
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Diabetes mellitus and obstructive pulmonary disease. Is there an association?
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
COPD Comorbidity Network: Connecting the dots
Source: Annual Congress 2013 –Highlights in epidemiology of respiratory disease
Year: 2013
The impact of input from a psychologist on a cohort of asthmatic frequent fliers
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Influence of psychological characteristics of patients for asthma control
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Effectiveness of a comprehensive management program of fragile COPD patients
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
Comorbidities and COPD severity: The French Palomb cohort
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
The importance of dyspnea and airflow limitation for anxiety and depression in COPD
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept